Analysis of the effect of biological therapy on SARS-CoV-2-specific antibody levels following booster vaccination in patients with inflammatory bowel disease

Project

Analysis of the effect of biological therapy on SARS-CoV-2-specific antibody levels following booster vaccination in patients with inflammatory bowel disease

Automatically Closed · 2022 until 2023

Brand Stephan, König Marius, Dütschler Joel, Krieger-Grübel Claudia, Eckhold Annika, Truniger Samuel, Frei Nicola Fabian, Albrich Werner

Type

Clinical Studies

Range

Multicentric, KSSG as main centre

Units

Gastroenterology/Hepatology, Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Division of Infectious Diseases, Infection Prevention and Travel Medicine

Status

Automatically Closed

Start Date

2022

End Date

2023

Financing

KSSG, Self Financed

Partner

Inselspital Bern

Brief description/objective

This is a national multi-center cohort confirmatory study which is designed as a prospective
observational trial combined with retrospective data collection. Prospective data are collected
through a patient questionnaire and assessment of blood samples taken at inclusion.
Retrospective data are collected manually from patient medical records. The study design is
based on the CLARITY study.